Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4466_Библиотеки_им_академика_М_И_Перельмана
.pdf
298
https://t.me/medicina_free
B. Bursal Duramaz et al.
In patients 6–18years old:
– If there is no history of PCV13 or PPSV23, one dose of PCV13 and one dose of
PPSV23 after at least 8weeks.
– If there is any PCV13 but no PPSV23, one dose of PPSV23 at least 8weeks after
the last dose of PCV13.
– If PPSV23 is present, but PCV13 is absent, one dose of PCV13 at least 8weeks
after the last dose of PPSV23.
– When both PCV13 and PPSV23 are indicated, administer PCV13 rst. PCV13
and PPSV23 should not be administered during the same visit [61–63].
Vaccination with an age-appropriate meningococcal conjugate vaccine (MCVACWY) against meningococcal serogroups A, C, W, and Y, and meningococcal B
vaccine is recommended for children at high risk for meningococcal disease (e.g.,
asplenia, and complement, factor D, and factor H deciencies). In MCVs, capsular
polysaccharides of N. meningitidis A, C, W, and Y serogroups are conjugated to the
diphtheria toxin mutant CRM197 (ACWY-CRM), the tetanus toxoid (ACWY-TT),
and the diphtheria toxin (ACWY-D). The minimum age is 2 months for MCVACWY- CRM and MCV-ACWY-TT and 9 months for MCV-ACWY-D [63].
Serogroup B meningococcal vaccines have also been approved in children (≥2
months old) at high risk for meningococcal disease. Adolescents and other risk
groups should also be vaccinated to reduce nasopharyngeal colonization and provide immunity [64].
22.9 Conclusion
Recurrent meningitis in children is a rare but life-threatening phenomenon and
increases the likelihood of repeated hospitalization of the child, with multiple and
invasive risks. A detailed history and physical examination should form the basis
of the evaluation. The patient should be questioned in detail about hearing impairment, speech delay, head trauma, rhino/ear discharge, recurrent infections, and
family history of immunodeciency. Physical examination should be done very
carefully to evaluate for head and midline abnormalities. It generally poses a diagnostic challenge. An organized approach and early diagnosis of any underlying
abnormality are essential and may be vital to preventing further attacks and improving the outcome for the affected patient. Vaccination of patients also plays a crucial
role in preventing recurrence.
References
1. Tebruegge M, Curtis N.Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev. 2008;21:519–37.
2. Livingston RA, Harrison CJ. Recurrent meningitis. In: Long SS, Prober CG, Fischer M,
Kimberlin DW, editors. Principles and practice of pediatric infectious diseases. 6th ed.
Philadelphia: Elsevier; 2023. p.305–10.

22 Recurrent Meningitis, Congenital Defects, andHearing Loss
https://t.me/medicina_free
3. Gao B, Yang J, Zhuang S, etal. Mollaret meningitis associated with an intraspinal epidermoid
cyst. Pediatrics. 2007;120:220–4.
4. Kriss TC, Kriss VM, Warf BC.Recurrent meningitis: the search for the dermoid or epidermoid
tumor. Pediatr Infect Dis J. 1995;14:697–700.
5. Quartier P, Foray S, Casanova J, etal. Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal uid by polymerase chain reaction. Pediatr Infect Dis J. 2000;19:1106–8.
6. Lunardi P, Missori P, Fraioli B.Chemical meningitis: unusual presentation of a cerebellar
astrocytoma: case report and review of the literature. Neurosurgery. 1989;25:264–70.
7. Uchida Y, Matsubara K, Wada T, etal. Recurrent bacterial meningitis by three different pathogens in an isolated asplenic child. J Infect Chemother. 2012;18:576–80.
8. Driel V, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW. Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands,
1988-2005. Clin Infect Dis. 2008;47:42–51.
9. Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, Gans J.Community-acquired recurrent bacterial meningitis in adults. Clin Infect Dis. 2007;45:46–51.
10. Brouwer MC, Tunkel AR, van de Beek D.Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2011;23:467–92.
11. Black J, Hickson L, Black B, Khan A.Paediatric cochlear implantation: adverse prognostic
factors and trends from a review of 174 cases. Cochlear Implants Int. 2014;15:62–77.
12. Biswas S, Millward CP, Riordan A, Sinha A, Avula S.Craniopharyngeal duct: a cause of recurrent meningitis. BJR Case Rep. 2015;1(3):20150022.
13. Cantatore S, Crisa A, Guaraldi N, Pancaldi ME, Iughetti L.Recurrent pneumococcal meningitis in a child with transethmoidal encephalocele: a case report and review of literature.
Minerva Pediatr. 2011;63:119–24.
14. Jain A, Tullu MS, Agrawal M, Jadhav DU.Occult encephalocele causing recurrent meningitis.
Pediatr Neurol. 2015;53:270–1.
15. Muzzi E, Battelino S, Gregori M, Pellegrin A, Orzan E.Life-threatening unilateral hearing
impairments. Review of the literature on the association between inner ear malformations and
meningitis. Int J Pediatr Otorhinolaryngol. 2015;79:1969–74.
16. Lee E, Lee EH, Yum MS, Ko TS.Recurrent bacterial meningitis in pediatric patients with
anatomical defects. J Korean Child Neurol Soc. 2011;19:102–8.
17. Fishman AJ. Imaging and anatomy for cochlear implants. Otolaryngol Clin N Am.
2012;45:1–24.
18. Glueckert R, Rask-Andersen H, Sergi C, etal. Histology and synchrotron radiation-based
microtomography of the inner ear in a molecularly conrmed case of CHARGE syndrome.
Am J Med Genet A. 2010;152:665–73.
19. Goddard JC, Meyer T, Nguyen S, Lambert PR.New considerations in the cause of spontaneous cerebrospinal uid otorrhea. Otol Neurotol. 2010;31:940–5.
20. Anandi S, Tullu MS, Bhatia S, Agrawal M.Mondini dysplasia as a cause for recurrent bacterial
meningitis: an early diagnosis. J Child Neurol. 2012;27:1052–5.
21. Kohrmann M, Schellinger PD, Wetter A, Hahnel S.Nasal meningoencephalocele, an unusual
cause for recurrent meningitis: case report and review of the literature. J Neurol. 2007;254:259–60.
22. Lucas MJ, Brouwer MC, van de Beek D.Neurological sequelae of bacterial meningitis. J
Infect. 2016;73:18–27.
23. Masri A, Alassaf A, Khuri-Bulos N, Zaq I, Hadidy A, Bakri FG.Recurrent meningitis in children: etiologies, outcome, and lessons to learn. Childs Nerv Syst. 2018;34:1541–7.
24. Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D.Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24:557–91.
25. Kutz JW, Simon LM, Chennupati SK, Giannoni CM, Manolidis S. Clinical predictors for
hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg.
2006;132:941–5.
26. Arditi M, Mason EO Jr, Bradley JS, etal. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102:1087–97.
299

300
https://t.me/medicina_free
27. Panuganti SK, Nadal S.Acute bacterial meningitis beyond the neonatal period. In: Long SS,
Prober CG, Fischer M, Kimberlin DW, editors. Principles and practice of pediatric infectious
diseases. 6th ed. Philadelphia: Elsevier; 2023. p.286–97.
28. Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM.Hearing
loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction.
Pediatrics. 2003;112:1049–53.
29. Roine I, Pelkonen T, Cruzeiro ML, Kataja M, Peltola H, Pitkaranta A.Hearing impairment and
its predictors in childhood bacterial meningitis in Angola. Pediatr Infect Dis J. 2013;32:563–5.
30. Edmond K, Clark A, Korczak VS, Sanderson C, Grifths UK, Rudan I.Global and regional
risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.
Lancet Infect Dis. 2010;10:317–28.
31. Durisin M, Bartling S, Arnoldner C, et al. Cochlear osteoneogenesis after meningitis in
cochlear implant patients: a retrospective analysis. Otol Neurotol. 2010;31:1072–8.
32. Lieu JE, Tye-Murray N, Fu Q. Longitudinal study of children with unilateral hearing loss.
Laryngoscope. 2012;122:2088–95.
33. Masuda S, Usui S, Matsunaga T. High prevalence of inner-ear and/or internal auditory
canal malformations in children with unilateral sensorineural hearing loss. Int J Pediatr
Otorhinolaryngol. 2013;77:228–32.
34. Carrol ED, Latif AH, Misbah SA.Recurrent bacterial meningitis: the need for sensitive imaging. BMJ. 2001;323:501–3.
35. Joshi VM, Navlekar SK, Kishore GR, Reddy KJ, Kumar VEC.CT and MR imaging of the
inner ear and brain in children with congenital sensorineural hearing loss. Radiographics.
2012;32:683–98.
36. Park AH, Kou B, Hotaling A, Azar-Kia B, Leonetti J, Papsin B.Clinical course of pediatric
congenital inner ear malformations. Laryngoscope. 2000;110:1715–9.
37. Stein LK, Jabaley T, Spitz R, Stoakley D, McGee T.The hearing-impaired infant: patterns of
identication and habilitation revisited. Ear Hear. 1990;11:201–5.
38. Bachmann-Harildstad G. Diagnostic values of beta-2 transferrin and beta-trace protein as
markers for cerebrospinal uid stula. Rhinology. 2008;46:82–5.
39. Ziu M, Savage JG, Jimenez DF. Diagnosis and treatment of cerebrospinal uid rhinorrhea
following accidental traumatic anterior skull base fractures. Neurosurg Focus. 2012;32:e3.
40. Chan DT, Poon WS, Ip CP, Chiu PW, Goh KY.How useful is glucose detection in diagnosing
cerebrospinal uid leak? The rational use of CT and beta-2 transferrin assay in detection of
cerebrospinal uid stula. Asian J Surg. 2004;27:39–42.
41. Stone JA, Castillo M, Neelon B, Mukherji SK.Evaluation of CSF leaks: high-resolution
CT compared with contrast-enhanced CT and radionuclide cisternography. AJNR Am J
Neuroradiol. 1999;20:706–12.
42. Lloyd MN, Kimber PM, Burrows EH.Posttraumatic cerebrospinal uid rhinorrhoea: modern
high-denition computed tomography is all that is required for the effective demonstration of
the site of leakage. Clin Radiol. 1994;49:100–3.
43. LaFata V, McLean N, Wise SK, DelGaudio JM, Hudgins PA.CSF leaks: correlation of highresolution CT and multiplanar reformations with intraoperative endoscopic ndings. AJNR
Am J Neuroradiol. 2008;29:536–41.
44. Mostafa BE, Khafagi A.Combined HRCT and MRI in the detection of CSF rhinorrhea. Skull
Base. 2004;14:157–62.
45. Zapalac JS, Marple BF, Schwade ND.Skull base cerebrospinal uid stulas: a comprehensive
diagnostic algorithm. Otolaryngol Head Neck Surg. 2002;126:669–76.
46. Tuntiyatorn L, Laothammatas J.Evaluation of MR cisternography in diagnosis of cerebrospinal uid stula. J Med Assoc Thail. 2004;87:1471–6.
47. Presutti L, Mattioli F, Villari D, Marchioni D, Alicandri-Ciufelli M.Transnasal endoscopic
treatment of cerebrospinal uid leak: 17 years’ experience. Acta Otorhinolaryngol Ital.
2009;29:191–6.
B. Bursal Duramaz et al.

22 Recurrent Meningitis, Congenital Defects, andHearing Loss
https://t.me/medicina_free
48. Kasiakou SK, Rafailidis PI, Liapropoulos K, Falagas ME. Cure of posttraumatic recurrent multiresistant gram-negative rod meningitis with intraventricular colistin. J Infect.
2005;50:348–52.
49. Verma RK, Tripathi N, Panda NK.Recurrent pyogenic meningitis and Mondini dysplasia:
surgeons nightmare-our experience. Int J Pediatr Otorhinolaryngol Extra. 2012;7:175–8.
50. Wilson MN, Simon LM, Arriaga MA, Nuss DW, Lin JA. The management of spontaneous
otogenic CSF leaks: a presentation of cases and review of literature. J Neurol Surg B Skull
Base. 2014;75:117–24.
51. Ozcan C, Vayisoglu Y, Gorur K, Yildiz A, İsmi O, Kuyucu N.Mondini dysplasia presenting
with recurrent meningitis. J Int Adv Otol. 2010;6:415–8.
52. Isaak AM, Faig AB, Martínez S, et al. Recurrent meningitis due to anatomical defects: the
bacteria indicates its origin. An Pediatr (Barc). 2015;82:388–396 [article in Spanish, abstract
in English].
53. Rupa V, Agarwal I, Rajshekhar V. Congenital perilymph stula causing recurrent meningitis: lessons learnt from a single-institution case series. Otolaryngol Head Neck Surg.
2014;150:285–91.
54. Gonzalez JR, Mattingly JK, Cass SP.Stapes footplate deformity leading to perilymphatic stula and recurrent meningitis. Int J Pediatr Otorhinolaryngol Extra. 2017;17:31–5.
55. Kamogashira T, Akamatsu Y, Kashio A, etal. Development of auditory skills after cochlear
implantation in children with inner ear malformations. Acta Otolaryngol. 2016;136:78–82.
56. Tunkel AR, Hasbun R, Bhimraj A, etal. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis.
2017;64:34–65.
57. Friedman JA, Ebersold MJ, Quast LM.Posttraumatic cerebrospinal uid leakage. World J
Surg. 2001;25:1062–6.
58. Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B.Prophylactic administration of ceftriaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical
trial. J Neurosurg. 2004;101:757–61.
59. Ratilal B, Costa J, Sampaio C.Antibiotic prophylaxis for preventing meningitis in patients
with basilar skull fractures. Cochrane Database Syst Rev. 2006:CD004884.
60. Baltas I, Tsoulfa S, Sakellariou P, Vogas V, Fylaktakis M, Kondodimou A.Posttraumatic meningitis: bacteriology, hydrocephalus, and outcome. Neurosurgery. 1994;35:422–6.
61. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine
and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising
conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Morb Mortal Wkly Rep. 2012;61:816–9.
62. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6–18 years
with immunocompromising conditions: recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:521–4.
63. Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years and younger—United States 2022. CDC; 2022. https://www.
cdc.gov/vaccines/schedules/downloads/child/0- 18yrs- child- combined- schedule.pdf. Accessed
22 Dec 2022.
64. Kaaijk P, van der Ende A, Luytjes W.Routine vaccination against MenB: considerations for
implementation. Hum Vaccin Immunother. 2013;10:310–6.
301

Focal Suppurative Infections
https://t.me/medicina_free
oftheCentral Nervous System
23
inChildren andHearing Loss
TaylanÇelik, MustafaHacımustafaoğlu, andDennisChua
23.1 Introduction
Cerebral sinus thrombosis (CST) is a severe cerebrovascular disease that can cause
adverse outcomes such as hearing loss (HL), although it is rare in children. Today,
it is being diagnosed more frequently due to the widespread use of neuroimaging,
more prolonged survival of children with a tendency to thrombosis, and increased
clinical awareness. It should be kept in mind when symptoms (after exclusion of
acute bacterial meningitis) such as unresponsive to treatment or headache and vomiting develop in infections such as recurrent and/or complicated acute bacterial rhinosinusitis, otitis media, and mastoiditis, especially in children with a tendency to
thrombosis. In such patients, it is important to evaluate the brain imaging for CST
in order not to miss the diagnosis.
T. Çelik (*)
Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine,
Çanakkale Onsekiz Mart University, Çanakkale, Türkiye
e-mail: taylanchelik@gmail.com
M. Hacımustafaoğlu
Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine,
Uludağ University, Bursa, Türkiye
e-mail: mkemal@uludag.edu.tr
D. Chua
Section of Otorhinolaryngology, ENT Surgeons Medical Centre, Mount Elizabeth Hospital,
Singapore, Singapore
e-mail: dennis.chua.yk@gmail.com
© The Author(s), under exclusive license to Springer Nature
Switzerland AG 2023
A. E. Arısoy et al. (eds.), Hearing Loss in Congenital, Neonatal and Childhood
Infections, Comprehensive ENT, https://doi.org/10.1007/978-3-031-38495-0_23
303

304
https://t.me/medicina_free
T. Çelik et al.
23.2 Septic Dural Sinus Thrombosis
23.2.1 Dural Venous Sinuses: Dural Sinus, Cerebral Sinus,
andCranial Sinus
The dural venous sinuses, the main venous drainage systems of the central nervous
system (CNS), are the venous channels located in the cranium, on the inner surface
of the bone, and between the endosteal and meningeal layers of the dura mater [1].
The cerebral venous system consists mainly of a network of supercial cortical,
medullary, and deep cerebral veins that drain into the dural sinuses [2]. Cerebral
venous return generally drains into the nearest venous sinuses, followed by drainage
into the internal jugular vein through the transverse (lateral) and sigmoid sinuses
(Figs.23.1 and 23.2). In addition, they provide normal physiological drainage of
cerebrospinal uid (CSF), such as absorption and discharge into the dural sinuses
through arachnoid villi that penetrate the dura from the subarachnoid area and reach
the dural sinuses (Fig.23.3).
Central nervous system venous circulation shows some differences from venous
circulation in other body systems; veins usually do not run parallel to the arteries,
cerebral veins are very thin due to the absence of muscular layers, and they do not
have venous valves. In addition, there is an extensive collateral system in the cortical, deep veins, and sinuses, which contributes to the continuation of venous drainage by alternative routes when the primary pathway is disabled. There may also be
signicant individual differences in the cerebral venous drainage system. Therefore,
it is helpful to consider these factors in the clinical and radiological evaluation of a
patient with septic venous sinus thrombosis.
6
Fig. 23.1 Brain major dural sinus systems. (Courtesy Taylan Çelik, MD)
1
2 3
7
8
54
9
1- Supeior sagittal sinus
2- Inferior sagittal sinus
3- Right transverse sinus
4- Left ophthalmic vein
5- Left cavernous sinus
6- Inter-cavernous sinus
7- Right sigmoid sinus
8- Left ınternal juguler ven
9- Left ear

Emissary veins
Transverse sinus
Sigmoid sinus
Internal Juguler vein Internal Juguler vein
l
23 Focal Suppurative Infections of the Central Nervous System in Children…
https://t.me/medicina_free
Superior sagittal sinus Inferior sagittal sinus
Confluence of sinuses Transverse sinus
305
Petrosal sinus
Ophhalmic vein Sigmoid sinus
Cavernous sinus Petrosal sinus
Fig. 23.2 Cerebral venous ow chart
Superior sagial sinus
Emissary vein
Cerebral vein
Dura mater
Aracnoid mater
Pia mater
Diploic vein
Arachnoid granulaon vil
Bone
Subarachnoid space
Cerebral cortex
Fig. 23.3 Schematic view of the arachnoid membrane, arachnoid granulation, dura mater, and
cerebral venous sinus relationship in the brain; arachnoid granulations originating from the arachnoid membrane reach the venous sinuses pass the dura from appropriate places and provide cerebrospinal uid drainage. (Courtesy Taylan Çelik, MD)
23.2.2 Cerebral Sinus Thrombosis
Cerebral sinus thrombosis describes a set of disorders that include thrombosis of the
cerebral venous system; it can be septic or aseptic. In Europe and North America,
the incidence is estimated at 0.6 per 100,000 per year in childhood, with male

306
https://t.me/medicina_free
predominance (60–70%) and neonates accounting for 30–50% of the cases [1, 2].
Cerebral sinus thrombosis can be divided into three main sections: cavernous sinus
thrombosis (CavST), lateral (transverse) sinus thrombosis (LST), and superior sagittal sinus thrombosis (very rare).
This chapter will give general information about the cerebral dural sinuses (cavernous, lateral, and sagittal) and their thromboses, followed by the clinical, laboratory, and treatment approaches of septic CST, especially in children, and its
evaluations in terms of hearing loss.
T. Çelik et al.
23.2.2.1 Risk Factors
In general, CST occurs in previously healthy children, most commonly in the presence of or after mastoiditis (characterized by postauricular pain, swelling, erythema,
or tenderness) and head/neck infections such as sinusitis, dehydration, and iron deciency anemia. Other risk factors predisposing children to CST are inammatory
bowel disease, congenital heart diseases, cancer, autoimmune disorders, chronic
kidney disease, nephrotic syndrome, systemic lupus erythematosus, and other
chronic diseases [2, 3]. Local stasis that may occur in cerebral blood ow and conditions that may cause it (such as head trauma, CNS tumors, and intracranial surgery)
may predispose to CST and/or aggravate the existing CST condition [3]. In addition, hereditary causes of thrombophilia such as antithrombin deciency, protein C
and protein S deciency, factor V Leiden mutation, and homocysteinemia resulting
from methylenetetrahydrofolate reductase (MTHFR) gene mutation are prothrombotic genetic conditions. Acquired nephrotic syndrome and antiphospholipid antibodies are other causes that may be risk factors in etiology, which tend to cause
thrombosis in general, and are also the risk factors for CST, although not detected
in every patient. Approximately 10–20% of children with CST may develop a recurrent thrombotic venous event in the future, of which at least half develop as systemic rather than cerebral venous thrombosis [3].
23.2.2.2 Pathophysiology
There is no valve mechanism in the cerebral veins and sinuses. Thrombosis in the
venous system causes outow obstruction, congestion, subsequent capillary hydrostatic pressure increase, uid leakage into the interstitium, and edema. The increase
in hydrostatic capillary pressure above a certain level and the presence of edema
may lead to a decrease in arterial blood ow/supply and local ischemia in the brain
tissue and subsequently to neurological ndings. These physiopathological and
clinical ndings may cause different clinical ndings to be more pronounced in different regions, depending on neighboring structures [3]. When these physiopathological changes affect the cochlear system, it may cause hypoxia due to insufciency
of venous circulation in the cochlear system, and then, sensorineural HL (SNHL)
may develop. Sensorineural HL (unilateral or bilateral) may arise as thrombosis
reaches the cochlear or labyrinthine veins [4].

23 Focal Suppurative Infections of the Central Nervous System in Children…
https://t.me/medicina_free
307
23.2.2.3 Clinical Findings
In CST, since thrombosis causes cerebral ischemia, the most common complaints
that bring the patient to the clinician are severe headache, vomiting, and confusion
that progresses over days. In addition, some different complaints according to the
anatomical region may develop [1, 2]. For example, in CavST, proptosis, chemosis,
oculomotor nerve (cranial nerve [CN]-III), trochlear nerve (CN-IV), trigeminal
nerve (CN-V), and abducens nerve (CN-VI), involvement ndings and LST, otitis
signs, unilateral CN-V, and CN-VI ndings may develop. However, since the cerebral venous sinuses are interconnected, and there is no valve mechanism in the
sinuses, some similar clinical ndings can be shared in common. Mental status
changes vary in patients; sometimes, only irritability and sleepiness may occur, or
progression to stupor and coma may be seen [2]. In septic CST, in addition to the
neurological ndings secondary to thrombosis, ndings of adjacent region infection
such as sinusitis, persistent and/or inadequately treated acute otitis media (AOM),
and mastoiditis also accompany the clinical picture. Hearing loss in septic CST may
be of the sensorineural type due to the underlying chronic/persistent otitis (conductive type) or acute cochlear dysfunction, and the CN-VII is affected [5–7]. Most
(about 95%) of these are unilateral. Acute HL is dened as HL that develops suddenly within days [5, 8].
23.2.3 Septic Cerebral Sinus Thrombosis
Septic CST is not common. In addition, widespread symptoms and signs, which can
also be seen in other diseases, may lead to misinterpretation of clinical signs [1].
Therefore, overlooked cases may lead to an underestimation of the incidence. In this
respect, it is benecial for the physician to interpret the clinical ndings and physical examination rationally.
Septic CST may show some differences according to the regions where it is
involved. Here, the most common septic CavST, septic LST, and septic sagittal
sinus thrombosis will be discussed briey.
23.3 Septic Cavernous Sinus Thrombosis
23.3.1 Anatomy
The cavernous sinuses are located just lateral to the base of the sella turcica and the
sphenoid paranasal sinuses. They are nearly located at the center of the dural sinuses.
These irregularly shaped sinuses have multiple trabeculae that act as strainers to
trap bacteria; this feature explains why cavernous sinuses have a higher risk of
infection than other dural sinuses. The cavernous sinuses are connected by the sella
turcica and two intercavernous sinuses that run in front and behind the pituitary
gland and sella turcica (Figs.23.1 and 23.4). Therefore, especially if treatment is

308
https://t.me/medicina_free
T. Çelik et al.
1
2
3
4
5
6
7
Fig. 23.4 Cavernous sinus anatomy and adjacent structures (coronal section). (Courtesy Taylan
Çelik, MD)
98
1. Oculomotor nerve (Ⅲ)
2. Trochlear nerve (Ⅳ)
3. Ophtalmic nerve (Ⅴ
4. Maxillary nerve (Ⅴ
5. Abducens nerve (Ⅵ)
6. Internal carotid arter
7. Sphenoidal sinus
8. Sella turcica
9. Cavernous sinus
2
)
1
)
delayed, the event may spread to the other side via venous connections; then, bilateral infection may develop, and clinical ndings may be bilateral [1].
Some cranial nerves, including CN-III, CN-IV, ophthalmic (CNV1), and maxillary branches (V2) of CNV, can be counted and are located lateral to the cavernous
sinuses. The cranial nerve VI is located more medially in the cavernous sinus and
adjacent to the cavernous segment of the internal carotid artery (ICA) (Fig.23.3)
[1]. In CavST, in addition to the general symptoms, there may be varying degrees of
involvement of these nerves, and narrowing of the ICA may be detected in radiological images. Septic CavST is more common in sphenoid sinusitis due to its proximity to the sphenoid sinus (Fig.23.4). In addition, in facial infections, especially
around the nose (danger triangle), the venous circulation primarily drains into the
cavernous and other venous sinuses may increase the risk (Fig.23.5).
23.3.2 Microbiology
The organisms associated with septic CavST differ by the site of primary infection
[1, 9]; Staphylococcus aureus accounts for 70% of all infections and is usually asso-
ciated with facial infection or sphenoid sinusitis. Community-acquired methicillinresistant S. aureus (MRSA) has been reported with increasing frequency.
Streptococci (including Streptococcus pneumoniae, Streptococcus milleri, and viri-
dans group streptococci) are less common. However, in some studies, the most common (60%) microorganism was reported to be Streptococcus anginosus [9].
Anaerobes, Bacteroides spp., and Fusobacterium spp. are less common and are
primarily associated with concomitant sinus, tooth, or tonsil infections. Fungal
agents such as Rhizopus spp. and other mucormycosis agents, Aspergillus spp. and
Schizophyllum, are rarely reported.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
